Related by context. All words. (Click for frequent words.) 76 CYPHER ® Stent 74 placebo dexamethasone 73 CYPHER R Stent 72 ischemic cardiomyopathy 72 NATRECOR R 72 ximelagatran 72 TAXUS Stent 72 binary restenosis 71 nondiabetic patients 71 pegylated liposomal doxorubicin 71 definite stent thrombosis 70 NEVO 70 comparator arm 70 everolimus eluting stents 70 Doxil ® 70 sunitinib malate 70 Taxus Stent 70 rosuvastatin #mg 70 cinacalcet 70 everolimus eluting stent 70 paclitaxel eluting stents 70 CIMZIA ™ 70 TAXUS Liberte Stent 69 oxycodone CR 69 MACCE 69 XIENCE V stent 69 Cypher Stent 69 KRAS mutations occur 69 TAXUS Express Stent 69 FOLFOX4 69 CYPHER R Sirolimus eluting 69 angiographic outcomes 69 idraparinux 69 IFN alfa 69 CYPHER ® 69 oral diclofenac 69 mm Stent 69 levosimendan 69 NATRECOR ® 69 MitraClip device 68 mycophenolate mofetil 68 INTEGRILIN 68 OPCAB 68 sirolimus eluting stent 68 tapentadol ER 68 NEVO ™ 68 ATACAND 68 nonvertebral fracture 68 aldosterone antagonist 68 patients undergoing CABG 68 carotid artery stenting 68 endarterectomy 68 rFVIIa 68 perioperative mortality 68 DAPT 68 imipenem 68 intravenous bisphosphonates 68 TAXUS Liberte Long 68 sirolimus eluting stents 68 TMC# r 68 stable angina 68 oral Hycamtin 68 unstable angina UA 68 squamous histology 68 clodronate 68 CANCIDAS 67 XIENCE V PROMUS Stent 67 carboplatin paclitaxel 67 CIMZIA TM certolizumab pegol 67 mcg albinterferon alfa 2b 67 irbesartan 67 dalteparin 67 revascularization procedures 67 sirolimus stent 67 iniparib 67 rimonabant #mg 67 PASI scores 67 APTIVUS R 67 active comparator 67 TAXUS stent 67 deep venous thromboses 67 clopidogrel Plavix 67 standard chemotherapy regimen 67 preoperative chemotherapy 67 FluCAM arm 67 Thal Dex 67 ARCOXIA 67 pegylated interferon alfa 2b 67 β blockers 67 lopinavir r arm 67 ACUITY trial 67 chemoradiation therapy 67 TORISEL 67 decitabine 67 TRITON TIMI 67 prednisone prednisolone 67 carotid artery stenting CAS 67 ARIXTRA 67 relapsed MM 67 low dose Iluvien 67 gemcitabine Gemzar 67 EchoCRT 67 certolizumab 67 thromboembolic events 67 Stenting Trial CREST 67 stage IIIb IV 66 Stent thrombosis 66 ACTEMRA TM 66 recurrent VTE 66 ketorolac 66 anti arrhythmic drug 66 candesartan cilexetil 66 posaconazole 66 primary patency 66 PegIntron 66 revascularizations 66 unstable angina pectoris 66 transfemoral 66 RE LY ® 66 lipid lowering agents 66 micafungin 66 chemoradiotherapy 66 cytoreductive surgery 66 reinfarction 66 symptomatic VTE 66 doxorubicin docetaxel 66 complete cytogenetic response 66 postoperative mortality 66 gadobutrol 66 carotid endarterectomy CEA 66 unfractionated heparin UFH 66 Fludara 66 zotarolimus 66 postoperative chemotherapy 66 octreotide LAR 66 intravenous diuretics 66 recurrent glioblastoma multiforme 66 bronchial thermoplasty 66 plus dexamethasone 66 oxaliplatin Eloxatin 66 salmeterol fluticasone 66 PRECiSE 66 simvastatin ezetimibe 66 CYPHER ® Sirolimus eluting 66 coronary revascularization 66 cabazitaxel 66 #mg BID [001] 66 cilostazol 66 morphometric vertebral fractures 66 non valvular atrial 66 nadroparin 66 antiarrhythmic drug 66 CALGB # [002] 66 sorafenib Nexavar 66 FOLPI 66 Torisel 66 CABG surgeries 66 carotid stenting 66 nonrandomized 66 rt PA 66 GOUT 66 CIMZIA TM 66 paroxysmal AF 66 SEISMIC Trial 66 TAVR 66 EURIDIS 66 p = ns 66 plus prednisone 66 AGILECT R 66 evaluating tivozanib 66 teriflunomide 66 ARCALYST ® 66 paclitaxel eluting stent 66 carotid stents 66 zotarolimus eluting stent 66 aspirin clopidogrel 66 coronary stenting 66 liver transplant recipients 66 iodixanol 65 cediranib 65 invasive candidiasis 65 parecoxib 65 Atacand 65 symptomatic aortic stenosis 65 TAXUS VI 65 debulking surgery 65 chlorambucil 65 tamsulosin 65 sirolimus eluting 65 iniparib BSI 65 functional mitral regurgitation 65 MACUGEN 65 MitraClip 65 Amrubicin 65 atorvastatin #mg 65 mg BID dose 65 tenecteplase 65 mcg QD 65 eplerenone 65 hsCRP levels 65 enalapril 65 placebo controlled clinical 65 AZT zidovudine Retrovir 65 fluvastatin 65 COPAXONE R 65 underwent CABG 65 Pemetrexed 65 metastatic lung cancer 65 alemtuzumab treated 65 HORIZONS AMI trial 65 INCB# [003] 65 GnRH agonists 65 drug eluting coronary stents 65 ZOLINZA 65 locoregional recurrence 65 pancreatic adenocarcinoma 65 dabigatran etexilate 65 glargine 65 PRADAXA 65 ICD implants 65 ibandronate 65 chlorthalidone 65 defibrillator CRT D 65 locoregional disease 65 aldosterone antagonists 65 APTIVUS 65 HBeAg positive patients 65 FFR guided treatment 65 INTEGRILIN R 65 concurrent chemoradiation 65 pamidronate 65 rosuvastatin Crestor 65 ezetimibe simvastatin 65 nonoperative 65 thromboprophylaxis 65 ABSORB trial 65 VADT 65 Dabigatran 65 osteoporotic vertebral compression fractures 65 STRIDE PD 65 thromboembolism 65 elotuzumab 65 argatroban 65 tipranavir r 65 phase IIIb 65 XIENCE V demonstrated 65 underwent resection 65 deferiprone 65 APTIVUS r 65 carboplatin chemotherapy 65 coronary intervention 65 intravesical therapy 65 budesonide foam 65 methotrexate monotherapy 65 TAXUS IV 65 severe exacerbations 65 vandetanib 65 thrombocytopenic 65 docetaxel chemotherapy 65 SEROQUEL R 65 ticlopidine 65 MabCampath 65 doripenem 65 PROMUS 65 dose cytarabine 65 PROMUS Element Stent 65 arterial thromboembolic events 64 Subgroup analysis 64 Protelos 64 Drug eluting stent 64 advanced adenomas 64 onset atrial fibrillation 64 temsirolimus 64 Tavocept 64 LEXIVA r 64 hemodialysis patients 64 Renal Cell Carcinoma RCC 64 Aprotinin 64 Xelox 64 OZURDEX ® 64 lenalidomide dexamethasone 64 evaluating REVLIMID 64 basiliximab 64 HoLEP 64 drug eluting stent DES 64 PREZISTA r arm 64 Aspergillus infections 64 YERVOY 64 NSTE ACS 64 tirofiban 64 perioperative morbidity 64 Engerix B 64 adjuvant radiotherapy 64 Ozurdex 64 Endeavor stent 64 SPIRIT IV 64 Proleukin 64 lipid lowering drugs 64 SCIg 64 cardiac resynchronization 64 SYNTAX trial 64 acute coronary syndromes ACS 64 bivalirudin 64 adult chronic ITP 64 protease inhibitor PI 64 Operative mortality 64 ticagrelor 64 adjuvant radiation 64 azacitidine 64 undergone radical prostatectomy 64 TKAs 64 tapentadol IR 64 Hazard Ratio 64 ARB telmisartan 64 NLX P# 64 Hycamtin ® 64 metastatic RCC 64 enoxaparin 64 GP IIb IIIa inhibitor 64 VFEND 64 PREZISTA r 64 riociguat 64 BRIM2 64 recurrent GBM 64 colorectal liver metastases 64 XELOX 64 briakinumab 64 chronic periodontitis 64 Velcade bortezomib 64 oral allopurinol 64 ROCKET AF 64 tamoxifen Nolvadex ® 64 ULORIC 64 LEUKINE 64 fondaparinux 64 nicardipine 64 IOP lowering 64 intravenous cyclophosphamide 64 mg kg dose 64 antithrombotics 64 clazosentan 64 repeat revascularization 64 nephron sparing surgery 64 steroid dexamethasone 64 patients undergoing percutaneous 64 strontium ranelate 64 tocilizumab 64 fosamprenavir 64 HBeAg negative patients 64 Coronary Artery Bypass Graft 64 DOXIL 64 ruboxistaurin 64 Resolute DES 64 receiving prophylactic anticoagulation 64 ICD therapy 64 BENICAR HCT 64 Nexavar sorafenib 64 YONDELIS 64 tigecycline 64 coronary interventions 64 relapsing remitting MS RRMS 64 lumbar spine BMD 64 retrospective cohort 64 Angiox R 64 CYPHER 64 RE LY 64 subgroup analyzes 64 Procoralan 64 antithrombotic therapy 64 ALND 64 TAXUS Liberte 64 carotid artery stenosis 64 lipid lowering therapy 64 Natalizumab 64 Viread Emtriva SUSTIVA 64 Zometa zoledronic acid 64 heparins 64 calcineurin inhibitors 64 thoracoscopic lobectomy 64 radical nephrectomy 64 abatacept 64 adalimumab 64 coronary artery bypass grafts 64 SUTENT 64 dacarbazine chemotherapy 64 nesiritide 64 Hycamtin 64 candesartan 64 venlafaxine XR 64 coinfected patients 64 events MACE 64 beta blocker therapy 64 daunorubicin 64 TAXUS TM 64 zoledronic acid Zometa 64 5-FU/LV 64 NAVISTAR R 64 percutaneous vertebroplasty 64 MADIT CRT 64 Cotavance 64 prostate TURP 64 Angiomax monotherapy 64 Vascular Wrap 63 neoadjuvant therapy 63 interferon ribavirin 63 Mitral valve repair 63 tenofovir emtricitabine 63 zoledronate 63 Telmisartan 63 ularitide 63 symptomatic paroxysmal AF 63 carotid artery stent 63 liver resection 63 intra abdominal abscess 63 microbiological eradication 63 coxib 63 AVOREN 63 LV dysfunction 63 dyslipidaemia 63 platelet inhibitor 63 Combo Stent 63 IV NSCLC 63 Vandetanib 63 esomeprazole 63 multivessel disease 63 lamivudine monotherapy 63 postmenopausal osteoporotic women 63 thromboembolic complications 63 titrated glipizide 63 vertebral compression fractures 63 metastatic HRPC 63 infusional 5-FU/LV 63 ritonavir boosted lopinavir 63 Vfend 63 events SAEs 63 paricalcitol 63 alfuzosin 63 oral FTY# 63 Coronary artery bypass graft 63 carotid revascularization 63 CsA 63 postoperative atrial fibrillation 63 malignant neoplasm 63 thrombolytic agents 63 XIENCE V Everolimus Eluting 63 crizotinib PF # 63 Endeavor DES 63 mcg BID 63 trabectedin 63 noninfectious uveitis 63 thiazide diuretic 63 adalimumab Humira 63 Arixtra 63 XGEVA 63 Candesartan 63 plus methotrexate 63 atorvastatin Lipitor 63 methotrexate therapy 63 Nesiritide 63 ExTRACT TIMI 63 resynchronization therapy 63 cisplatin vinorelbine 63 postoperative morbidity 63 chemotherapy gemcitabine 63 ReoPro 63 oral anticoagulant therapy 63 nadolol 63 TEMODAL 63 basal bolus regimen 63 Flu Cy 63 TNF antagonist 63 Fludara ® 63 letrozole Femara 63 CYPHER R stent 63 Neulasta R 63 osteoporotic compression fractures 63 chronic GVHD 63 Epoetin alfa 63 lopinavir r 63 achieved ACR# 63 retinal vein occlusion 63 Anti Bacterial Envelope 63 carotid surgery 63 dose statin therapy 63 degarelix 63 Burch colposuspension 63 metastatic GIST 63 Retisert 63 adjunctive placebo 63 MYCAMINE 63 sargramostim 63 drotrecogin alfa activated 63 chemoembolization 63 Dynesys 63 OAB symptoms 63 liposomal doxorubicin 63 NYHA Class II 63 chemotherapeutic regimens 63 bezafibrate 63 HuMax EGFr 63 MADIT CRT trial 63 Degarelix 63 malignant pleural mesothelioma 63 Zyclara 63 TMP SMX 63 bendamustine 63 tolvaptan 63 oral rivaroxaban 63 dexmedetomidine 63 Dr. Kandzari 63 uncoated stent 63 CHAMPION PCI 63 VTE prophylaxis 63 Camptosar ® 63 baseline HbA1c 63 MGd 63 Catheter ablation 63 dacarbazine 63 chemoradiation 63 hepatic metastases 63 Betaferon R 63 antihypertensive therapy 63 HydroCoil 63 ONTARGET 63 pertuzumab 63 ZACTIMA 63 hip resurfacing arthroplasty 63 NPH insulin 63 unfractionated heparin 63 mitoxantrone plus 63 eluting stents 63 Elitek 63 ARIMIDEX 63 LPV r 63 endophthalmitis 63 cerebrovascular events 63 #mg doses [002] 63 PREZISTA ritonavir 63 intravitreal injections 63 melphalan prednisone 63 EDSS scores 63 TEAEs 63 MAGE A3 ASCI 63 postintervention 63 pain palliation 63 Cordis Cypher 63 placebo controlled Phase III 63 amoxicillin clavulanate 63 Viread Emtriva Sustiva 63 interferon beta therapy 63 intracranial stenosis 63 paclitaxel eluting 63 Carotid Revascularization Endarterectomy vs. 63 CRESTOR #mg 63 angiographic restenosis 63 HBeAg seroconversion 63 Sanofi Aventis Taxotere 63 PRADAXA #mg 63 NEUPOGEN 63 pomalidomide 63 Acute Ischemic Stroke 63 Vectibix monotherapy 63 salpingo oophorectomy 63 oral anticoagulation 63 percutaneous transluminal coronary angioplasty 63 AVONEX ® 63 docetaxel Taxotere ® 63 SYNERGY Stent 63 thromboembolic 63 otamixaban 63 dose melphalan 63 nonvertebral fractures 63 radial artery grafts 63 LAGB 63 IFN beta 63 inhaled cyclosporine 63 Zemplar Capsules 63 desvenlafaxine succinate 63 Edwards SAPIEN valve 63 deferoxamine 63 carotid endarterectomy 63 trials RCTs 63 oncologic outcomes 63 infliximab monotherapy 63 lymphadenectomy 63 eribulin 63 p# biomarker 63 subtrochanteric 63 LNG IUS 63 RoACTEMRA 63 Pegintron 63 statin monotherapy 63 tipranavir 63 Afatinib 63 p = NS 63 flutamide 63 elevated troponin 62 Retisert TM 62 biologic DMARD 62 VIAject ™ 62 PREZISTA rtv 62 splenectomized 62 Subgroup analyzes 62 Cytoxan 62 zalutumumab 62 recurrent DVT 62 rivaroxaban 62 SilverHawk Plaque Excision System 62 Irinotecan 62 apremilast 62 Navelbine 62 Sirolimus eluting Coronary Stent 62 telmisartan 62 oxycodone IR 62 metastatic CRC 62 FluCAM 62 receiving VICTRELIS 62 FOLFIRI 62 brivaracetam 62 ACCORD Lipid 62 carotid artery blockage 62 candidemia 62 REMICADE ® 62 #mg dose [002] 62 AROMASIN 62 Multicenter Automatic Defibrillator Implantation 62 epoetin alfa 62 SPIRIT FIRST 62 phase IIb clinical 62 abacavir lamivudine 62 thalidomide Thalomid 62 gefitinib Iressa 62 CMV disease 62 undergoing coronary artery 62 oblimersen 62 CALGB 62 thrombus aspiration 62 achieved CCyR 62 chronic angina 62 darapladib 62 retransplantation 62 risedronate 62 biphasic insulin aspart 62 benazepril 62 ancrod 62 PHPT 62 EXJADE 62 extrapleural pneumonectomy 62 inhaled treprostinil 62 stenting procedures 62 VaD 62 gp# vaccine 62 Bivalirudin 62 Vascugel 62 primary hypercholesterolemia 62 percutaneous intervention 62 ZYVOX 62 dose atorvastatin 62 Kaplan Meier analysis 62 ivabradine 62 RLAI 62 RRMS patients 62 trastuzumab Herceptin ® 62 uncontrolled hypertension 62 Femara letrozole 62 CR nPR 62 ENDEAVOR clinical 62 virologic breakthrough 62 LVEF 62 AA Amyloidosis 62 ADHF 62 hypercholesterolaemia 62 metformin monotherapy 62 mycophenolate mofetil MMF 62 vicriviroc 62 peginterferon alfa 2a 62 TAXUS 62 lenalidomide Revlimid R 62 5-fluorouracil/leucovorin 62 TTF Therapy 62 Neulasta ® 62 somatostatin analog 62 randomized multicenter trial 62 Evicel 62 abdominal hysterectomy 62 Perforomist Inhalation Solution 62 esophageal erosions 62 BCIRG 62 gauge vitrectomy 62 prospective multicenter 62 hepatectomy 62 axitinib 62 thromboses 62 solifenacin 62 discontinuations due 62 HeFH 62 genotypic resistance 62 repigmentation 62 docetaxel prednisone 62 doxorubicin cyclophosphamide 62 fluticasone salmeterol 62 unresectable tumors 62 trabeculectomy 62 Epirubicin 62 HBeAg negative 62 transapical 62 cardiac resynchronisation therapy 62 ß blockers 62 COPAXONE R glatiramer acetate 62 composite endpoint 62 DU #b 62 PEGINTRON TM 62 xanthine oxidase inhibitor 62 HCV RESPOND 2 62 TNF alpha inhibitor 62 neurologic progression 62 Advagraf 62 asymptomatic carotid stenosis 62 ALLHAT 62 ENDEAVOR IV 62 Jevtana 62 preintervention 62 oral deforolimus 62 TAXUS Liberte stent 62 total thyroidectomy 62 intracranial hemorrhage ICH 62 VIRAMUNE 62 acyclovir Lauriad R 62 efavirenz EFV 62 androgen deprivation 62 follicular lymphomas 62 antihypertensive medications 62 rituximab Rituxan 62 NHANES III 62 symptomatic BPH 62 AGILECT ® 62 Bare Metal Stent 62 alteplase 62 esophagectomy 62 sorafenib Nexavar ® 62 poor metabolizers 62 MELD scores 62 5FU 62 ER CHOP 62 refractory AML 62 epoetin beta 62 Coronary Stent 62 severe mitral regurgitation 62 #Gy 62 PICSO ® 62 BRAF inhibitor 62 H. pylori eradication 62 locoregional 62 venous thromboembolic events 62 glycated hemoglobin levels 62 Temsirolimus 62 Tocilizumab 62 nonmelanoma skin cancers 62 metastatic malignant 62 visceral metastases 62 AVANDIA 62 elective PCI 62 eptifibatide 62 randomized controlled clinical trials 62 Pegasys peginterferon alfa 2a 62 Kivexa 62 TAXOTERE ® 62 reintervention 62 NovoTTF 62 docetaxel Taxotere 62 paroxetine Paxil 62 GnRH agonist 62 caspofungin 62 mRCC 62 adenoma recurrence 62 HSCT 62 efalizumab 62 neoadjuvant 62 HbA 1c levels 62 CYPHER R Sirolimus Eluting 62 EBRT 62 symptomatic intracranial 62 nonsmall cell lung cancer 62 Vidaza azacitidine 62 GEM OS1 62 nonoperative treatment 62 galiximab 62 biliary tract cancer 62 calcineurin inhibitor 62 retropubic 62 ejection fractions 62 Aloxi injection 62 TYSABRI natalizumab 62 IEQ kg 62 TG MV 62 percutaneous interventions 62 antiarrhythmic drugs 62 Pfizer Sutent 62 Carotid endarterectomy 62 gemcitabine carboplatin 62 Genous stent 62 venous thromboembolisms 62 divalproex sodium 62 canakinumab 62 Potiga 62 bowel resection 62 NMIBC 62 IV bisphosphonates 62 Zemplar 62 adrenalectomy 62 COPAXONE ® 62 GP IIb IIIa inhibitors 62 BARI 2D 62 Lantus ® 62 CRVO 62 diameter stenosis 62 hemodynamically significant 62 NeoRecormon 62 bypass graft CABG surgery 62 CLARITY study 62 IIIa inhibitor 62 colorectal adenoma 62 relapsed CLL 62 Sapien valve 62 LUX Lung 62 Moxifloxacin 62 dosage regimens 62 TroVax ® 62 FROVA 62 BAY #-# 62 BoNTA 62 Carotid stenting 62 low dose cytarabine 62 Targretin 62 RSD# oral 62 ritonavir boosted 62 venlafaxine Effexor 62 pegylated interferon alfa 62 stent DES 62 interferon gamma 1b 62 pCR 62 fenofibric acid 62 Balloon Kyphoplasty 62 metastatic renal cell carcinoma 62 ELOXATIN 62 CHARM Added 62 Abciximab 62 antiplatelet drugs 62 MIRAPEX 62 adriamycin 62 non squamous NSCLC 62 oral ridaforolimus 62 pioglitazone Actos 62 corticosteroid therapy 62 darunavir r 62 landmark ATHENA trial 61 Ceplene/IL-2 61 olaparib 61 valsartan 61 extrapyramidal symptoms 61 interferon alfa 2b 61 transarterial 61 reteplase 61 Non inferiority 61 pioglitazone HCl 61 regorafenib 61 adjuvant tamoxifen 61 colectomy 61 Gliadel Wafer 61 GORE VIABAHN Endoprosthesis 61 Folfox 61 stage IIIB 61 RSR# efaproxiral 61 adefovir 61 evaluable subjects 61 moxifloxacin 61 Acute Decompensated Heart Failure 61 Increlex ® 61 ZoMaxx 61 Complication rates 61 inhibitor RG# 61 RAPAFLO R 61 FOLFOX4 alone 61 multicenter placebo controlled 61 pharmacologically active isomer 61 RTOG 61 capecitabine Xeloda 61 prasugrel Effient 61 Pivotal Clinical Trial 61 macrovascular disease 61 renal tumors 61 percutaneous coronary interventions 61 mcg doses 61 Vernakalant 61 goserelin 61 INC# 61 hyperphenylalaninemia HPA due 61 occlusive disease 61 sotalol 61 peginterferon alfa 2a Pegasys 61 splenectomized patients 61 MYDICAR ® 61 acute myocardial infarction AMI 61 ABVD 61 DEFLUX 61 folinic acid 61 transaminase elevations 61 Navelbine ® 61 cIAI 61 Baseline characteristics 61 gemcitabine chemotherapy 61 relapsed ovarian cancer 61 STN stimulation 61 CYT# potent vascular disrupting 61 PCIs 61 Cimzia ® certolizumab pegol 61 gastrointestinal GI motility disorders 61 Aptivus ® 61 antiarrhythmic 61 clinically meaningful efficacy 61 pegylated interferon alpha 61 mCi kg 61 CIPN 61 complete remissions 61 bivalirudin alone 61 atherosclerotic renal artery stenosis 61 Nilotinib 61 ToGA 61 superficial bladder cancer 61 underwent liver transplantation 61 Ticagrelor 61 glitazone 61 cerebral angiography 61 gastrointestinal toxicities 61 dapagliflozin plus 61 experienced virologic failure 61 ALGRX 61 acute decompensated heart 61 hepatorenal syndrome 61 Tacrolimus 61 sirolimus 61 mg Proellex 61 stent thromboses 61 interferon alfa 61 statin Crestor 61 Eluting Coronary Stent System 61 MERLIN TIMI 61 dual antiplatelet therapy 61 atherothrombotic disease 61 plus gemcitabine 61 hematologic toxicity 61 MERREM 61 ® lenalidomide 61 Herceptin trastuzumab 61 #mg dosing group 61 dronedarone 61 prucalopride 61 EUS FNA 61 landmark ATHENA 61 relapsed SCLC 61 coated stent 61 lumiracoxib 61 PARTNER Trial 61 thromboembolic disease 61 Betaferon ® 61 antiplatelet agent 61 NNT = 61 Clinical Outcomes Utilizing Revascularization 61 radical retropubic prostatectomy 61 TAXUS Express 61 MMSE scores 61 cardiac toxicity 61 Cystectomy 61 Gemzar ® 61 dutasteride 61 lumiliximab 61 Cimzia TM 61 thoracic aortic aneurysms 61 conventional angiography 61 mapatumumab 61 Raptiva ® 61 parathyroidectomy 61 valdecoxib 61 clobazam 61 bicalutamide 61 malignant neoplasms 61 vertebral fracture 61 multicenter randomized controlled 61 Taxotere ® 61 liposomal amphotericin B 61 postoperative infection 61 TAXUS Express2 61 teriparatide 61 aortic root replacement 61 Acute Coronary Syndromes ACS 61 angiotensin receptor blocker ARB 61 pazopanib 61 Certican 61 Durezol